Broad-spectrum antiviral drugs
Recent pandemic threats caused by new and old virus infections have emphasized the urgent need to develop drugs that not only target the life cycle of the virus but also boost the immune system in such a way that the virus can be effectively recognized by the immune system and then finally eliminated. In recent years, more attention has been focused on how to modulate the immune system with the objective to treat various virus infections. In cancer research, immune checkpoints inhibitors are molecules that regulate (stimulate or inactivate) the immune cells. This knowledge have also been subject to intensive preclinical and clinical research in development of virus infections and resulted in an increased understanding how to develop drugs that effectively treat virus infections.